Revance Therapeutics | RVNC - UTANG



UTANG Perubahan Tanggal
AbbVie USD 72.86B 5.36B 2026-03
ALKERMES USD 1.58B 1.51B 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 43.37B 867M 2026-03
J&J USD 54.99B 7.05B 2026-03
Merck USD 49.12B 222M 2026-03
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
P&G USD 37.03B 387M 2026-03
Pacira USD 363.12M 4.53M 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06